PKM and Autoimmunity: In addition, PKM2 is upregulated upon in vitro activation of mouse and human CD4 T cells, and PKM2 is capable of phosphorylation and accumulates in the nucleus [98], serving as a potential target for treating T cell-mediated autoimmunity.